State Biomonitoring Programs: Assessing disproportionate exposure to environmental chemicals among communities

The summary for the State Biomonitoring Programs: Assessing disproportionate exposure to environmental chemicals among communities grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control NCEH, which is the U.S. government agency offering this grant.

State Biomonitoring Programs: Assessing disproportionate exposure to environmental chemicals among communities: The purpose of this notice of funding opportunity is to leverage existing capability and capacity of state public health laboratories to conduct high-quality biomonitoring science and assess human exposure to environmental chemicals within their jurisdictions, specifically focusing on investigations for populations disproportionately affected by exposure to harmful chemicals. Improved exposure assessment will enable states to reduce or eliminate exposure to certain environmental chemicals in at-risk population groups and assess the effectiveness of interventions to reduce harmful exposures. Applicants may propose biomonitoring activities based on one or both of the following strategies to complete during a 3-year funding cycle. 1. Community biomonitoring investigations which can be a new investigation in an affected community or surveillance activities in a previously exposed community, 2. State-wide population surveillance with oversampling of a minority group disproportionately affected by harmful chemical exposure. Recipient activities will include biomonitoring to assess exposures of concern, enhancement of laboratory capability/expertise, coordination/collaboration with partners to improve exposure investigations, and reporting of findings to key audiences.